
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. GunjanRead More
The cost of developing a new drug roughly doubles everyRead More
In medicine, a Biomarker is a biological indicator, which canRead More
The growth of the pharmaceutical and biotechnology industry depends on successful clinical trials. The cost of developing a new drug that gets approval is estimated at around $2-3 billion. The longer the trial lasts and the more patients it has involved, the larger the loss. The researchers at Johns Hopkins Bloomberg School of Public Health …
Five Reasons to Embrace Data-Driven Drug Development Read More »